The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
The Russian National Research Medical University named after N.I. Pirogov

Porshina O.V.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Zatorskaya N.F.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Grebenyuk V.N.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Valitova I.V.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Gumennaia E.R.

Russian Children’s Clinical Hospital is a branch of the Federal State Autonomous Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation

Orlova K.A.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Kasikhina E.I.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology;
Peoples’ Friendship University of Russia (RUDN University)

Golousenko I.Yu.

Russian University of Medicine

Udzhukhu V.Yu.

Peoples’ Friendship University of Russia (RUDN University);
Pirogov Russian National Research Medical University

Olmsted syndrome caused by heterozygous missense mutation in TRPV3 gene

Authors:

Potekaev N.N., Porshina O.V., Zatorskaya N.F., Grebenyuk V.N., Valitova I.V., Gumennaia E.R., Orlova K.A., Kasikhina E.I., Golousenko I.Yu., Udzhukhu V.Yu.

More about the authors

Read: 969 times


To cite this article:

Potekaev NN, Porshina OV, Zatorskaya NF, et al. Olmsted syndrome caused by heterozygous missense mutation in TRPV3 gene. Russian Journal of Clinical Dermatology and Venereology. 2025;24(3):297‑303. (In Russ.)
https://doi.org/10.17116/klinderma202524031297

References:

  1. Elise Tonoli R, De Villa D, Hübner Frainer R, et al.Olmsted syndrome. Case Rep Dermatol Med. 2012;2012:927305. https://doi.org/10.1155/2012/927305
  2. Olmsted HC. Keratodermia palmaris et plantaris congenitalis: case report showing concomitant lesions of unusual localization. Am J Dis Child. 1927;33(5):757-764. 
  3. Duchatelet S, Hovnanian A. Olmsted syndrome: clinical, molecular and therapeutic aspects. Orphanet J Rare Dis. 2015 Mar 17;10:33.  https://doi.org/10.1186/s13023-015-0246-5
  4. Gatault S, Kirby B, Danso-Abeam D. Comment on «Olmsted Syndrome». Case Rep Dermatol Med. 2020 Jun 3;2020:8024981. https://doi.org/10.1155/2020/8024981
  5. Bhayana AA, Prasad P, Bhayana AA. Olmsted syndrome. Indian J Ophthalmol. 2022 Jul;70(7):2765. https://doi.org/10.4103/ijo.IJO_132_22
  6. Korotkiy NG, Botkina AS, Tikhomirov AA. The case of Olmsted syndrome in a 2-year-old child. Pediatria. 2019;98(2):259-262. (In Russ.). https://doi.org/10.24110/0031-403X-2019-98-2-259-262
  7. Bhayana AA, Prasad P, Bhayana AA. Olmsted syndrome. Indian J Ophthalmol. 2022 Jul;70(7):2765. https://doi.org/10.4103/ijo.IJO_132_22
  8. Slesarenko NA, Morrison AV, Marchenko VM, Moiseev AA, Ulanova AV, Dobdina AY. A clinical case of diagnosis of a very rare form of keratoderma in a child. Saratov Journal of Medical Science. 2018;14(4):763-765. (In Russ.).
  9. Eytan O, Fuchs-Telem D, Mevorach B, Indelman M, Bergman R, Sarig O, Goldberg I, Adir N, Sprecher E. Olmsted syndrome caused by a homozygous recessive mutation in TRPV3. J Invest Dermatol. 2014 Jun;134(6):1752-1754. https://doi.org/10.1038/jid.2014.37
  10. Lin Z, Chen Q, Lee M, Cao X, et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet. 2012 Mar 9;90(3):558-564.  https://doi.org/10.1016/j.ajhg.2012.02.006
  11. Cheng X, Jin J, Hu L, Shen D, et al. TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell. 2010 Apr 16; 141(2):331-343.  https://doi.org/10.1016/j.cell.2010.03.013
  12. Bang S, Yoo S, Yang TJ, et al. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol. 2012 Feb;165(3):683-692.  https://doi.org/10.1111/j.1476-5381.2011.01568.x
  13. Guo Y, Song Y, Liu W, Wang T, et al. Novel Insights into the Role of Keratinocytes-Expressed TRPV3 in the Skin. Biomolecules. 2023 Mar 10;13(3):513.  https://doi.org/10.3390/biom13030513
  14. Choi JY, Kim SE, Lee SE, et al. Olmsted Syndrome Caused by a Heterozygous p.Gly568Val Missense Mutation in TRPV3 Gene. Yonsei Med J. 2018 Mar;59(2):341-344.  https://doi.org/10.3349/ymj.2018.59.2.341
  15. Danso-Abeam D, Zhang J, Dooley J, et al.Olmsted syndrome: exploration of the immunological phenotype. Orphanet J Rare Dis. 2013 May 21;8:79.  https://doi.org/10.1186/1750-1172-8-79
  16. Mevorah B, Goldberg I, Sprecher E, et al. Olmsted syndrome: mutilating palmoplantar keratoderma with periorificial keratotic plaques. J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S266-72.  https://doi.org/10.1016/j.jaad.2005.03.036
  17. Greco C, Leclerc-Mercier S, Chaumon S, et al. Use of epidermal growth factor receptor inhibitor erlotinib to treat palmoplantar keratoderma in patients with Olmsted syndrome caused by TRPV3 mutations. JAMA Dermatol. 2020;156(2):191-195.  https://doi.org/10.1001/jamadermatol.2019.4126
  18. Spitz KE, Chu L, Lawley LP. Treatment of TRPV3 mutation-associated Olmsted syndrome with erlotinib. JAAD Case Rep. 2022 Jun 7;25:83-85.  https://doi.org/10.1016/j.jdcr.2022.05.029

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.